[O-29] 一般演題口演セッション29 治療創薬、再生医療2

[O-29-6] Early onset of efficacy with erenumab for migraine prevention in Japanese patients

^○Sunfa Cheng¹, Hirata Koichi², Takeshima Takao³, Sakai Fumihiko⁴, Imai Noboru⁵, Matsumori Yasuhiko⁶, Tatsuoka Yoshihisa⁷, Yoshida Ryuji⁸, Peng Cheng⁹, Mikol D.. Daniel¹ (1.Global Development, Amgen Inc., Thousand Oaks, CA, USA, 2.Headache Center, Department of Neurology, Dokkyo Medical University, 3.Headache Center, Department of Neurology, Tominaga Hospital, 4.Saitama International Headache Center, 5.Department of Neurology, Japanese Red Cross Shizuoka Hospital, 6.Sendai Headache and Neurology Clinic, 7.Department of Neurology, Tatsuoka Neurology Clinic, 8.Research & Development, Amgen K.K., 9.Global Biostatistical Science, Amgen Inc.)